China-based private investigators receive prison terms

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

China-based private investigators receive prison terms

Peter Humphrey and Yu Yingzeng, the China-based investigators hired by GlaxoSmithKline to investigate corruption allegations, have been sentenced to 30 months and 24 months respectively for illegally obtaining private information

In a one-day trial, the Shanghai Intermediate Number One Court found that the British Humphrey (right) and Yu, his American wife, broke the law by illegally obtaining private information in the course of their investigations. In addition to the jail sentences, Humphrey received a RMB 200,000 fine ($32,500), while Yu was fined RMB 150,000. Humphrey will also be deported.

Humphrey and Yu have 10 days to appeal.

Donald Clarke of the Chinese Law Prof Blog has a copy of the Chinese language transcript posted by the court.

Humphrey and Yu are the founders of the private investigation firm ChinaWhys. In April 2013, GlaxoSmithKline hired the firm to investigate an anonymous email alleging that GSK employees were engaging in an elaborate bribery scheme. The detailed allegations also contained a video of GSK China head Mark Reilly in what appeared to be his Shanghai apartment.

In July 2013 Chinese authorities arrested Humphrey and Yu. Humphrey soon after issued an apology on Chinese television for his company's actions and said that he never intended to break Chinese law. GSK also admitted that its China-based executives had engaged in illegal activities.

The ChinaWhys case has been closely watched by international companies, as many regularly rely on private investigators to conduct due diligence on investments, business partners and other aspects of its business. This is especially true in IP enforcement, where companies often engage investigators to track down the sources of counterfeit goods.





more from across site and SHARED ros bottom lb

More from across our site

Amita Haylock discusses building an integrated Asia practice as clients increasingly demand that firms combine IP, technology and data expertise
François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
Gift this article